Cargando…
DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma is one of the most aggressive cancers, with high mortality in the United States. One of the important signal transduction proteins involved in the regulation of pancreatic cancer’s aggressive progression is the nuclear export protein (XPO1). High expression of XPO1 h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721494/ https://www.ncbi.nlm.nih.gov/pubmed/31382411 http://dx.doi.org/10.3390/cancers11081101 |
_version_ | 1783448355954753536 |
---|---|
author | Azmi, Asfar S. Li, Yiwei Aboukameel, Amro Muqbil, Irfana Philip, Philip A. Mohammad, Ramzi M. |
author_facet | Azmi, Asfar S. Li, Yiwei Aboukameel, Amro Muqbil, Irfana Philip, Philip A. Mohammad, Ramzi M. |
author_sort | Azmi, Asfar S. |
collection | PubMed |
description | Pancreatic ductal adenocarcinoma is one of the most aggressive cancers, with high mortality in the United States. One of the important signal transduction proteins involved in the regulation of pancreatic cancer’s aggressive progression is the nuclear export protein (XPO1). High expression of XPO1 has been found in pancreatic, lung, breast and other cancers and lymphomas with a poor prognosis of patients with tumors and high proliferative activity of cancer cells. Because XPO1 exports multiple tumor suppressor proteins simultaneously from the nucleus, the inhibition of XPO1 may retain multiple tumor suppressors in the nucleus, resulting in the suppression of cell proliferation and the induction of apoptosis in tumors. In this study, we found that the high expression of XPO1 in pancreatic cancer cells could be, in part, due to the methylation of the miR-30 gene, leading to the low expression level of the miR-30 family. By co-transfection of the XPO1 3′-UTR-Luc target vector with miR-30 mimic, we found that XPO1 is a direct target of the miR-30 family. We also observed that the enforced expression of the miR-30 family inhibited the expression of XPO1, resulting in the suppression of pancreatic cancer growth both in vitro and in vivo. These findings could help to design a novel therapeutic strategy for the treatment of pancreatic cancer by introducing miR-30 into cancer cells. |
format | Online Article Text |
id | pubmed-6721494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67214942019-09-10 DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma Azmi, Asfar S. Li, Yiwei Aboukameel, Amro Muqbil, Irfana Philip, Philip A. Mohammad, Ramzi M. Cancers (Basel) Article Pancreatic ductal adenocarcinoma is one of the most aggressive cancers, with high mortality in the United States. One of the important signal transduction proteins involved in the regulation of pancreatic cancer’s aggressive progression is the nuclear export protein (XPO1). High expression of XPO1 has been found in pancreatic, lung, breast and other cancers and lymphomas with a poor prognosis of patients with tumors and high proliferative activity of cancer cells. Because XPO1 exports multiple tumor suppressor proteins simultaneously from the nucleus, the inhibition of XPO1 may retain multiple tumor suppressors in the nucleus, resulting in the suppression of cell proliferation and the induction of apoptosis in tumors. In this study, we found that the high expression of XPO1 in pancreatic cancer cells could be, in part, due to the methylation of the miR-30 gene, leading to the low expression level of the miR-30 family. By co-transfection of the XPO1 3′-UTR-Luc target vector with miR-30 mimic, we found that XPO1 is a direct target of the miR-30 family. We also observed that the enforced expression of the miR-30 family inhibited the expression of XPO1, resulting in the suppression of pancreatic cancer growth both in vitro and in vivo. These findings could help to design a novel therapeutic strategy for the treatment of pancreatic cancer by introducing miR-30 into cancer cells. MDPI 2019-08-02 /pmc/articles/PMC6721494/ /pubmed/31382411 http://dx.doi.org/10.3390/cancers11081101 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Azmi, Asfar S. Li, Yiwei Aboukameel, Amro Muqbil, Irfana Philip, Philip A. Mohammad, Ramzi M. DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma |
title | DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma |
title_full | DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma |
title_fullStr | DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma |
title_full_unstemmed | DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma |
title_short | DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma |
title_sort | dna-methylation-caused downregulation of mir-30 contributes to the high expression of xpo1 and the aggressive growth of tumors in pancreatic ductal adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721494/ https://www.ncbi.nlm.nih.gov/pubmed/31382411 http://dx.doi.org/10.3390/cancers11081101 |
work_keys_str_mv | AT azmiasfars dnamethylationcauseddownregulationofmir30contributestothehighexpressionofxpo1andtheaggressivegrowthoftumorsinpancreaticductaladenocarcinoma AT liyiwei dnamethylationcauseddownregulationofmir30contributestothehighexpressionofxpo1andtheaggressivegrowthoftumorsinpancreaticductaladenocarcinoma AT aboukameelamro dnamethylationcauseddownregulationofmir30contributestothehighexpressionofxpo1andtheaggressivegrowthoftumorsinpancreaticductaladenocarcinoma AT muqbilirfana dnamethylationcauseddownregulationofmir30contributestothehighexpressionofxpo1andtheaggressivegrowthoftumorsinpancreaticductaladenocarcinoma AT philipphilipa dnamethylationcauseddownregulationofmir30contributestothehighexpressionofxpo1andtheaggressivegrowthoftumorsinpancreaticductaladenocarcinoma AT mohammadramzim dnamethylationcauseddownregulationofmir30contributestothehighexpressionofxpo1andtheaggressivegrowthoftumorsinpancreaticductaladenocarcinoma |